Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
A federal jury in Texas has ordered Johnson & Johnson and a subsidiary to pay $482 million to an inventor who claimed the health care giant infringed on his patent for a cardiac stent.
Jurors in the U.S. District Court Eastern District of Texas returned the verdict Friday against Johnson & Johnson and Cordis Corp.
Heart stents are mesh-wire tubes that prop open coronary arteries after surgery to remove fatty plaque.
Jurors found that a stent built and distributed by Cordis willfully infringed on plaintiff Dr. Bruce Saffran's patent.
Saffran previously won a patent infringement judgment against Boston Scientific Corp., which agreed in 2009 to pay $50 million to settle the dispute.
Officials at Johnson & Johnson weren't immediately available to comment.